DOSSIER · UPDATED 18 NOV 2025

Kimia Therapeutics

Unlocking deeper insights from empirical data in the pursuit of better medicines.

kimiatx.com ↗Claim this profile

Founded: 2022
Headcount: 18
Open roles: 0
Last raised: Series A · $55M

SECTION I · THE BRIEF

Inside Kimia Therapeutics

Brief #03845Updated 18 NOV 2025BERKELEYSOFTWARE COMPANIESSERIES A

Employbl Dossier

Kimia Therapeutics

Unlocking deeper insights from empirical data in the pursuit of better medicines.

Founded: 2022
Headcount: 18
Open roles: 0
Last raised: Series A · $55M

Section II · Premium ProfileMembers only

01Engineering interview process at Kimia TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Kimia Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Stig Hansen

CEO at Kimia Therapeutics

Kimia TherapeuticsCarmot TherapeuticsSunesis PharmaceuticalsUniversity of California BerkeleyKøbenhavns Universitet - University of Copenhagen

Jack Sadowsky

Vice President at Kimia Therapeutics

Kimia TherapeuticsCarmot TherapeuticsGenentechUCSFUniversity of Wisconsin-MadisonUniversität LeipzigUniversity of Wisconsin-MadisonPomona College

OPEN ROLES

Hiring at Kimia Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $55,000,000